New York, New York - Canopy, the first Intelligent Care Platform for oncology, today announced results from a 21-month, real-world study demonstrating that electronic patient-reported outcomes (ePROs) can help identify common side effects in lung cancer patients receiving immunotherapy, both as monotherapy and in combination with chemotherapy. The Identification of key symptomatic differences in patients with shorter duration of therapy could suggest that aggressive early management can extend time on therapy, leading to improved outcomes.
ePROs, or electronic patient-reported outcomes, are reported to increase survival by over 20% when integrated into routine cancer care. Earlier recognition of treatment toxicity keeps a small problem from becoming a big problem yet offering opportunities for regular patient reporting is often easier said than done. Facilities worry that adopting new digital tools for patients, like symptom reporting, will lead to decreased efficiency or increased administrative burden for their already burnt-out teams. Will this cause more work for me? Will anyone use this? Are we wasting money? These are just some of the most common questions practices ask themselves. However, the right technology partner and toolset can ensure that care teams can boost patient outcomes without becoming overwhelmed by administrative headaches.
Patients today expect to engage with their healthcare providers from anywhere and at any time. The digital movement in healthcare has been underway for some time with the rise of mobile phone use over the last two decades, improved patient portals, and new generations who are digital natives. Even before the pandemic, many patients were already doing most of their medical research online and accessing specific health data like lab reports and vaccination records, through patient portals. By 2019, 86% of patient portal users were already viewing test results online and 32% had begun sharing information with other providers for referrals or second opinions.
Socioeconomic status, race, and location can all have enormous impacts on the cancer outcome of a patient. When we think of a cancer diagnosis, we often think in stages or grades and forget that the day-to-day life of a patient has just as much of an impact on their long-term outcome.
Canopy, the first Intelligent Care Platform for oncology, today announced results from a seventeen-month, real-world study of their ePRO-based patient monitoring platform. The single-site study of 923 patients at Highlands Oncology Group demonstrates the Canopy platform can be effectively implemented at a large scale with a high level of long-term patient enrollment, engagement, and retention. The study also found that the vast majority of patient issues were effectively resolved by nurse specialists and physician intervention was infrequently required.
Oncologists and oncology providers want the best for their patients, recognizing that being diagnosed with cancer is devastating, treatment is hard, and bad things can happen despite best efforts. They also understand patient expectations, doing everything possible to deliver an easier journey, the highest quality of life, and the best outcomes. Innovation is expected in oncology, with physicians and providers driving support for clinical trials and new treatment options, including the advancement of health technologies. As a result, we are now at a point where the evolution of the care delivery model, including the use of remote patient monitoring via electronic patient-reported outcomes (ePROs), needs to occur.
